Does This Study Prove Monsanto Company is Killing Our Honey Bees?

A class of insecticides has long been claimed to be at the root of the demise of honey bee populations. Do the data show that Monsanto, Bayer, and Syngenta are to blame?

May 19, 2014 at 11:00AM


Are we on the verge of losing nature's pollinators? Source: Muhammad Mahdi Karim/ Wikimedia Commons.

A new Harvard study claims to have found a link between neonicotinoids, a class of insecticides that disrupts the neural function of various types of insects, and the declining populations of honey bees. Long suspected of being responsible for colony collapse disorder, neonics may have finally been proven as the smoking gun activists have been looking for. Of course, as is often the case, many headlines seized on the emotional opportunity presented by the conclusions of the study rather than remaining critical of the research methods used.

There are some major red flags being thrown up by beekeepers about the methodology employed in the study. And no, they aren't being paid off by companies such as Bayer (NASDAQOTH:BAYRY), Syngenta (NYSE:SYT), and Monsanto (NYSE:MON). They simply know their craft and want to nudge the discussion back to the facts. What do investors and consumers need to know about the study?

Important background information
It's critical to go over a few things before we dig into the study. First, Monsanto doesn't produce a single neonicotinoid, although it is developing a new portfolio of products that could save honey bees. Bayer CropScience and Syngenta combine to produce four of the eight neonicotinoids on the market today, which account for roughly 85% of sales for the class of pesticides.

Second, honey bee populations face a host of challenges each year, but the notion that we're witnessing a catastrophic decline simply isn't true. The United States Department of Agriculture compiles an annual report on the estimated number of honey bee colonies in the U.S., as reported by beekeepers. The data don't paint an apocalyptic picture.


Third, you may want to think twice about protesting neonicotinoids under the guise that they somehow harm mammals. That is, without sufficient data to back up such claims. The truth is, if you own a cat or dog and protect it against fleas or ticks with Advantage products, then you're applying Bayer's imidacloprid -- the world's most successful neonic and the active ingredient of the Advantage product line -- directly to your beloved family pet.


I'll bet Fido is doing just fine. Besides, neonics are much less toxic than the classes of insecticides they replaced (that's why the market shifted to the class of molecules in the first place).

Beekeepers take on the study
The beef with the leading researcher of the study, Dr. Chensheng Lu, actually dates back to a flawed study from 2012 that claimed the cause of colony collapse disorder was simply the application of imidacloprid to corn, which then ended up in the high fructose corn syrup being fed to honey bees. Few beekeepers or scientists supported the study. The uproar made Dr. Lu attempt to replicate similar results in the recent study by feeding honey bees high fructose corn syrup laced with the same neonic. Unfortunately, prominent beekeepers are once again questioning the results from the latest research (link opens PDF).

Biologist and beekeeper Randy Oliver is one of the loudest critics. It's important to remember that insecticides can certainly harm bee colonies, so it's in Oliver's interest to stay current on best practices and reduce the damage caused to his colonies and livelihood. You can read some of the flaws in Lu's approach on, but the most noteworthy stem from the fact that the researchers did not test for nosema parasites -- pretty important when tallying population declines. Additionally, the paper was reported in an obscure Italian journal (Bulletin of Insectology) rather than a prominent peer-reviewed publication. That does, unfortunately, carry some weight for the validity of the results.

Foolish takeaway
After reading through Randy Oliver's argument discussing the numerous flaws with Lu's study and the study itself, I don't think the researchers found anything of value. At this point, we cannot say that neonics alone are the leading contributor to honey bee population declines. That doesn't necessarily let Bayer and Syngenta off the hook for their use of neonics, or Monsanto for its use of pesticides that could have unintended effects on honey bees, but investors and consumers need to remember that multiple factors play a role in fluctuating bee populations. Parasitic fungi, parasitic mites, pesticides, temperature, and more likely combine to put pressure on honey bee colonies -- so it's irresponsible to focus on any one culprit in this case. For now, it appears that neonics are as risky as their current labels suggest. Nothing more, and nothing less.

Take advantage of this little-known tax "loophole"
Recent tax increases have affected nearly every American taxpayer. But with the right planning, you can take steps to take control of your taxes and potentially even lower your tax bill. In our brand-new special report "The IRS Is Daring You to Make This Investment Now!," you'll learn about the simple strategy to take advantage of a little-known IRS rule. Don't miss out on advice that could help you cut taxes for decades to come. Click here to learn more.

Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolioCAPS pageprevious writing for The Motley Fool, or his work for SynBioBeta to keep up with developments in the synthetic biology industry.

The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers